All Stories

  1. Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty Liver Disease

    Article • Current Pharmaceutical Design, April 2020, Bentham Science Publishers

    Luca Valenti

  2. Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update

    Article • Current Pharmaceutical Design, February 2019, Bentham Science Publishers

    Luca Valenti

  3. Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease

    Article • Liver International, October 2018, Wiley

    Luca Valenti

  4. Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease

    Article • Hepatology Communications, April 2018, Wiley

    Luca Valenti

  5. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

    Article • Journal of Internal Medicine, December 2017, Wiley

    Luca Valenti

  6. Mutant PNPLA3 I148M protein as pharmacological target for liver disease

    Article • Hepatology, August 2017, Wiley

    Luca Valenti

  7. Hepatic iron is the major determinant of serum ferritin in NAFLD patients

    Article • Liver International, July 2017, Wiley

    Luca Valenti, Dr. Oscar Borsani

  8. Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

    Article • Cancer Medicine, July 2017, Wiley

    Luca Valenti

  9. Editorial: new insights into the relationship between the intestine and non-alcoholic fatty liver-is “fatty gut” involved in disease progression?

    Article • Alimentary Pharmacology & Therapeutics, July 2017, Wiley

    Luca Valenti

  10. Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2017, Endocrine Society

    Professor daniela cabibi, Luca Valenti

  11. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

    Article • Liver International, June 2016, Wiley

    Luca Valenti

  12. Hepcidin resistance in dysmetabolic iron overload

    Article • Liver International, April 2016, Wiley

    Luca Valenti

  13. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage

    Article • Hepatology, January 2016, Wiley

    Luca Valenti

  14. Reply

    Article • Hepatology, July 2015, Wiley

    Luca Valenti

  15. Reply

    Article • Hepatology, June 2015, Wiley

    Luca Valenti

  16. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients

    Article • Hepatology, May 2015, Wiley

    Luca Valenti

  17. Particulate matter phagocytosis induces tissue factor in differentiating macrophages

    Article • Journal of Applied Toxicology, April 2015, Wiley

    Luca Valenti

  18. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    Article • Hepatology, January 2015, Wiley

    Luca Valenti

  19. The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.

    Article • Liver International, November 2014, Wiley

    Luca Valenti

  20. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance

    Article • European Journal of Clinical Investigation, June 2014, Wiley

    Luca Valenti, Dr Massimiliano Ruscica

  21. CDKN1A: A double-edged sword in fatty liver?

    Article • Cell Cycle, April 2014, Taylor & Francis

    Luca Valenti

  22. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B

    Article • Hepatology, October 2013, Wolters Kluwer Health

    Luca Valenti

  23. PNPLA3 Ile148Met variant and hepatocellular carcinoma: A matter of fat

    Article • Digestive and Liver Disease, December 2012, Elsevier

    Luca Valenti

  24. I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology

    Article • Hepatology, August 2012, Wolters Kluwer Health

    Luca Valenti

  25. Iron and the Adipocyte: Beware the Liver!

    Article • ImmunoGastroenterology, January 2012, Hong Kong STM Publishing Co., Ltd.

    Luca Valenti

  26. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease

    Article • World Journal of Gastroenterology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Luca Valenti

  27. Patatin-like phospholipase domain containing-3gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis

    Article • World Journal of Gastroenterology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Luca Valenti

  28. Modulation of Iron Metabolism and Hepcidin Release by HFE Mutations in Chronic Hemodialysis Patients: Pathophysiological and Therapeutic Implications

    Article • November 2011, IntechOpen

    Luca Valenti

  29. PNPLA3 I148M polymorphism and liver damage in obese children

    Article • The Journal of Pediatrics, November 2011, Elsevier

    Luca Valenti

  30. Patatin-like phospholipase domain-containing protein 3 genotype and hepatocellular carcinoma in chronic hepatitis C

    Article • Hepatology, May 2011, Wolters Kluwer Health

    Luca Valenti

  31. Reply†

    Article • Hepatology, April 2010, Wolters Kluwer Health

    Luca Valenti

  32. Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels #

    Article • Hepatology, February 2009, Wolters Kluwer Health

    Luca Valenti

  33. Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resistance

    Article • Hepatology, December 2008, Wolters Kluwer Health

    Luca Valenti

  34. HFE mutations in nonalcoholic fatty liver disease

    Article • Hepatology, May 2008, Wolters Kluwer Health

    Luca Valenti

  35. Turning up the heat in the fat cell

    Article • Nature Medicine, November 2004, Springer Science + Business Media

    Luca Valenti

  36. Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance

    Article • Gastroenterology, March 2003, Elsevier

    Luca Valenti

  37. TNFα Promoter Polymorphisms

    Article • Springer Science + Business Media

    Luca Valenti